Past work by Yoo and his colleagues, who pioneered this transformation technique using small RNA molecules called microRNAs, has focused on understanding the development of Huntington's disease -; an ...

Daniel J. Levitin's “I Heard There Was a Secret Chord” explores the many ways music can help heal our bodies and minds.

The Food and Drug Administration has granted Fast Track designation to PTC518 for the treatment of Huntington disease (HD).

Topical/skin directed therapies are best for early-stage disease or in combination with systemic therapies in advanced disease, according to Dr Arron Mangold.

A teacher from Chesapeake is determined to run in the NYC marathon following a life changing medical diagnosis.

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is ...

Loqus23 Therapeutics Ltd. has raised £35 million (US$46.6 million) in a series A to take forward small molecules it has discovered for the treatment of Huntington’s disease and other conditions that ...

Neurocrine Biosciences' stock dropped after a lackluster trial. Click here to read more about the potential for this biotech ...

The funds will support the development of LoQus23’s lead candidate, its MutSβ inhibitor, as it enters clinical development.

BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.

A new study has uncovered a startling revelation: rare genetic disorders caused by repetitive DNA sequences may be up to ...

Loqus23 Therapeutics Ltd. has closed a £35 million (US$43 million) series A financing, with the aim of supporting its work developing small-molecule somatic expansion inhibitors for the treatment of ...